Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Metastatic Prostate Cancer
Related studies linked through entity extraction aliases.
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Impact of Atorvastatin on Prostate Cancer Progression During ADT
- Status
- RECRUITING
- Phase
- PHASE3
The Role of Ga68-PSMA-11 PET Imaging in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
- Status
- COMPLETED
- Phase
- NA
I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO
- Status
- UNKNOWN
- Phase
- N/A
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia
- Status
- COMPLETED
- Phase
- N/A
Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide
- Status
- TERMINATED
- Phase
- PHASE2
Cannabis Oil and Radiation Therapy for the Management of Pain
- Status
- TERMINATED
- Phase
- PHASE2
Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
COMbination of Bipolar Androgen Therapy and Nivolumab
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects
- Status
- COMPLETED
- Phase
- PHASE2
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Phase I Trial of PACE for Metastatic Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1